Elphis Cell Therapeutics Secures $3.4M Series A Funding for Innovative Vascular Disease Treatment
Korean startup, Elphis Cell Therapeutics, which is developing personalized cell therapies for rare vascular diseases, has secured a 4 billion KRW...
Elphis Cell Therapeutics